3Schmidt Wolf IG,Lefterova P,Mehta BA,et al.Phenotypic characterization and identification of effecter cells involved in tumor cell recognition of cytokine-induced kill cells[J].Exp Hematol,1993,21(13):1673～1679.
4Vemeris MR,Kornacker V,Mailander V,et al.Resistance of exvivo expanded CD3^+CD56^+T cells to fast 2 mediated apoptosis[J].Cancer Immunol Immunot her,2000,49(15):335～345.
5Reichert TE,Day R,Wanger E M,et al.Absent or low expression of the zeta in T cells at the tumor site correlates with poor survival in patients with oral careinoma[J].Cancer Res,1998,58(23):5344.
6Schmidt-Wolif IG,Lefterova P,Johnston Vet al.Sensitivity of multidrug 2 resistant tumor cell lines to immunologic effector cells[J].Cell Immunol,1996,169(1):85～90.
7Fosepb C,Alvamas,Yeb-Cbing,et al.Expansion of cytotoxic CD3^+CD56^+cells from peripheral blood progentitor cells of undergoing autologous hematopoietic cell transplantion[J].Biology of Blood and Marrow Transplantion,2001,7:216～222.
8ELA A M,SCHMEDT2WOLF G H,WEISSMAN IL,et al.Two pathways of exocytosis of cytoplasmic granule cotents and target cell killing by cytokine-induced CD3CD56 killer cells[J].Blood,1995,86(9):3493～3499.
9Hongeng S,Prtvises S,Woraponpaiboon S,et al.Generation of CD3^+CD56^+cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells[J].Int J Hematol,2003,77:175.
